Bain Capital Life Sciences Investors, LLC
Olema Pharmaceuticals, Inc. · 10% Owner
Bain Capital Life Sciences Investors, LLC is listed in filings as 10% Owner at Olema Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through May 22, 2026, including purchase activity and sale activity. Recent filings connect the profile to Olema Pharmaceuticals, Inc. (OLMA), NewAmsterdam Pharma Company N.V. (NAMS), Heartflow, Inc. Common Stock (HTFL), and Rapid Micro Biosystems, Inc. (RPID). The current snapshot covers public activity from Dec 17, 2024 to May 22, 2026. Reported amounts are shown as $350 to $163. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $2M300k shares | BuyJan 8, 2025 | $5.76 | $11.07 | |
| $1631.6M shares | BuyDec 13, 2024 | $0.0001 | $31.68 | |
| $56M2M shares | SellFeb 4, 2026 | $28.05 | $24.56 | |
| $2M56.2k shares | SellApr 30, 2026 | $30.05 | $24.56 | |
| $26M892.5k shares | SellApr 30, 2026 | $29.18 | $24.56 | |
| $23M797.1k shares | SellApr 29, 2026 | $29.37 | $24.56 | |
| $8M254.1k shares | SellApr 28, 2026 | $30.51 | $24.56 |